Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
Akebia Therapeutics (Nasdaq: AKBA) said its executive team will participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:30 PM ET in New York City.
The company said a webcast of the presentation will be available after the conference via the Investors section at https://ir.akebia.com. The Piper Sandler conference runs December 2–4, 2025.
Akebia Therapeutics (Nasdaq: AKBA) ha detto che il suo team esecutivo parteciperà a un Fireside Chat alla Piper Sandler 37th Annual Healthcare Conference il martedì 2 dicembre 2025 alle ore 16:30 ET a New York. L'azienda ha detto che una trasmissione in webcast della presentazione sarà disponibile dopo la conferenza tramite la sezione Investors all'indirizzo https://ir.akebia.com. La Piper Sandler conference si svolge dal 2 al 4 dicembre 2025.
Akebia Therapeutics (Nasdaq: AKBA) anunció que su equipo ejecutivo participará en una Fireside Chat en la Piper Sandler 37th Annual Healthcare Conference el martes 2 de diciembre de 2025 a las 4:30 p.m. ET en la ciudad de Nueva York. La empresa dijo que una transmisión en webcast de la presentación estará disponible después de la conferencia a través de la sección Investors en https://ir.akebia.com. La Piper Sandler conference se celebra del 2 al 4 de diciembre de 2025.
Akebia Therapeutics (Nasdaq: AKBA)의 임원진은 Piper Sandler 37th Annual Healthcare Conference의 Fireside Chat에 2025년 12월 2일 화요일 동부표준시 16:30에 뉴욕시에서 참가할 예정이라고 발표했습니다. 회사는 발표의 웹캐스트가 컨퍼런스 이후 https://ir.akebia.com의 Investors 섹션에서 제공될 것이라고 밝혔습니다. Piper Sandler 컨퍼런스는 2025년 12월 2–4일에 걸쳐 진행됩니다.
Akebia Therapeutics (Nasdaq : AKBA) a déclaré que son équipe exécutive participera à une Fireside Chat lors de la Piper Sandler 37th Annual Healthcare Conference le mardi 2 décembre 2025 à 16 h 30 ET à New York. L'entreprise a indiqué qu'une diffusion en webcast de la présentation sera disponible après la conférence via la section Investors sur https://ir.akebia.com. La conférence Piper Sandler se tient du 2 au 4 décembre 2025.
Akebia Therapeutics (Nasdaq: AKBA) gab bekannt, dass das Führungsteam an einem Fireside Chat bei der Piper Sandler 37th Annual Healthcare Conference am Dienstag, 2. Dezember 2025 um 16:30 Uhr ET in New York teilnehmen wird. Das Unternehmen gab bekannt, dass eine Webcast-Präsentation nach der Konferenz über den Bereich Investors unter https://ir.akebia.com verfügbar sein wird. Die Piper Sandler-Konferenz findet vom 2. bis 4. Dezember 2025 statt.
Akebia Therapeutics (Nasdaq: AKBA) قالت إن فريقها التنفيذي سيشارك في Fireside Chat خلال Piper Sandler 37th Annual Healthcare Conference يوم الثلاثاء، 2 ديسمبر 2025 الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة في مدينة نيويورك. قالت الشركة إن البث المصور للعرض سيكون متاحاً بعد المؤتمر عبر قسم Investors على https://ir.akebia.com. يعقد مؤتمر Piper Sandler من 2 إلى 4 ديسمبر 2025.
- None.
- None.
CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that members of its executive team will participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2 at 4:30 PM EST.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.
The Piper Sandler Healthcare Conference will take place December 2-4, 2025, in New York City.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com